BACKGROUND:Patient navigation (PN) is being used increasingly to help patients complete screening colonoscopy (SC) to prevent colorectal cancer. At their large, urban academic medical center with an open-access endoscopy system, the authors previously demonstrated that PN programs produced a colonoscopy completion rate of 78.5% in a cohort of 503 patients (predominantly African Americans and Latinos with public health insurance). Very little is known about the direct costs of implementing PN programs. The objective of the current study was to perform a detailed cost analysis of PN programs at the authors' institution from an institutional perspective. METHODS: In 2 randomized controlled trials, average-risk patients who were referred for SC by primary care providers were recruited for PN between May 2008 and May 2010. Patients were randomized to 1 of 4 PN groups. The cost of PN and net income to the institution were determined in a cost analysis. RESULTS: Among 395 patients who completed colonoscopy, 53.4% underwentSC alone, 30.1% underwent colonoscopy with biopsy, and 16.5% underwent snare polypectomy. Accounting for the average contribution margins of each procedure type, the total revenue was $95,266.00. The total cost of PN was $14,027.30. Net income was $81,238.70. In a model sample of 1000 patients, net incomes for the institutional completion rate (approximately 80%), the historic PN program (approximately 65%), and the national average (approximately 50%) were compared. The current PN program generated additional net incomes of $35,035.50 and $44,956.00, respectively. CONCLUSIONS: PN among minority patients with mostly public health insurance generated additional income to the institution, mainly because of increased colonoscopy completion rates.
RCT Entities:
BACKGROUND:Patient navigation (PN) is being used increasingly to help patients complete screening colonoscopy (SC) to prevent colorectal cancer. At their large, urban academic medical center with an open-access endoscopy system, the authors previously demonstrated that PN programs produced a colonoscopy completion rate of 78.5% in a cohort of 503 patients (predominantly African Americans and Latinos with public health insurance). Very little is known about the direct costs of implementing PN programs. The objective of the current study was to perform a detailed cost analysis of PN programs at the authors' institution from an institutional perspective. METHODS: In 2 randomized controlled trials, average-risk patients who were referred for SC by primary care providers were recruited for PN between May 2008 and May 2010. Patients were randomized to 1 of 4 PN groups. The cost of PN and net income to the institution were determined in a cost analysis. RESULTS: Among 395 patients who completed colonoscopy, 53.4% underwent SC alone, 30.1% underwent colonoscopy with biopsy, and 16.5% underwent snare polypectomy. Accounting for the average contribution margins of each procedure type, the total revenue was $95,266.00. The total cost of PN was $14,027.30. Net income was $81,238.70. In a model sample of 1000 patients, net incomes for the institutional completion rate (approximately 80%), the historic PN program (approximately 65%), and the national average (approximately 50%) were compared. The current PN program generated additional net incomes of $35,035.50 and $44,956.00, respectively. CONCLUSIONS: PN among minority patients with mostly public health insurance generated additional income to the institution, mainly because of increased colonoscopy completion rates.
Authors: Iris Vogelaar; Marjolein van Ballegooijen; Deborah Schrag; Rob Boer; Sidney J Winawer; J Dik F Habbema; Ann G Zauber Journal: Cancer Date: 2006-10-01 Impact factor: 6.860
Authors: Christa E Martens; Trisha M Crutchfield; Jane L Laping; Lexie Perreras; Daniel S Reuland; Laura Cubillos; Michael P Pignone; Stephanie B Wheeler Journal: J Cancer Educ Date: 2016-12 Impact factor: 2.037
Authors: Steven H Itzkowitz; Sidney J Winawer; Marian Krauskopf; Mari Carlesimo; Felice H Schnoll-Sussman; Katy Huang; Thomas K Weber; Lina Jandorf Journal: Cancer Date: 2015-11-23 Impact factor: 6.860
Authors: Samir Gupta; Daniel A Sussman; Chyke A Doubeni; Daniel S Anderson; Lukejohn Day; Amar R Deshpande; B Joseph Elmunzer; Adeyinka O Laiyemo; Jeanette Mendez; Ma Somsouk; James Allison; Taft Bhuket; Zhuo Geng; Beverly B Green; Steven H Itzkowitz; Maria Elena Martinez Journal: J Natl Cancer Inst Date: 2014-03-28 Impact factor: 13.506
Authors: Michael Greenspan; Navdeep Chehl; Krista Shawron; Lisa Barnes; Hong Li; Elizabeth Avery; Shannon Sims; John Losurdo; Sohrab Mobarhan; Joshua Melson Journal: Dig Dis Sci Date: 2015-04-23 Impact factor: 3.199
Authors: Ji-Hyun Lee; William Fulp; Kristen J Wells; Cathy D Meade; Ercilia Calcano; Richard Roetzheim Journal: J Cancer Educ Date: 2014-03 Impact factor: 2.037
Authors: Karen E Kim; Fornessa Randal; Matt Johnson; Michael Quinn; Chieko Maene; Sonja Hoover; Valerie Richmond-Reese; Florence K L Tangka; Djenaba A Joseph; Sujha Subramanian Journal: Cancer Date: 2018-10-25 Impact factor: 6.860